4.5 Review

An introduction to adaptive designs and adaptation in CNS trials

Journal

EUROPEAN NEUROPSYCHOPHARMACOLOGY
Volume 21, Issue 2, Pages 153-158

Publisher

ELSEVIER
DOI: 10.1016/j.euroneuro.2010.09.004

Keywords

Adaptive design; Biomarker; Central Nervous System; Dose-ranging study; Seamless design

Ask authors/readers for more resources

Adaptive designs learn from accumulating trial data in real time and apply this knowledge to optimize subsequent study execution. A set of design rules define a priori which modifications may be incorporated into the trial design. Judicious use of adaptive designs may increase the information value per resource unit invested by avoiding allocation of patients to non-efficacious/unsafe therapies and allowing stopping decisions to be made at the earliest possible time point. Ultimately this may accelerate the development of promising therapies. (C) 2010 Elsevier B.V. and ECNP. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available